In light of the Egyptian Drug Authority’s (EDA) support for investment and increasing local manufacturing—and to ensure the availability of safe, high-quality, and effective medical products for the benefit of the Egyptian citizen—the Technical Committee for Drug has approved the proposal to include the (addition/transfer) of the intermediate manufacturing stage (Internal Bulk) within the modern manufacturing mechanism approved by the Chairman of the EDA for registered local human and veterinary medical products.